more news coming...."Sierra World Equity Review Nailed It!_Discussions With Eli Lilly and Company (LLY) Drive CytRx Corporation (CYTR) Shares Over 52% Higher Projects Sierra. "
"Yesterday Sierra and her team were the first to break the news regarding the likely coming buyout of CytRx Corporation (CYTR) by Eli Lilly and Company (LLY).
Eli Lilly and CytRx
Thursday's session saw another 52% plus gain for CytRx as institutional big money flowed into the stock, more green days ahead forecast accurate Sierra. Sierra’s leads indicate that the next round of meetings is expected to be Monday in Indianapolis. Sierra receives updates from her network throughout the day and posts instant updates. This Saturday afternoon join Sierra and her team as they discuss their leads and insight into this potential buyout! Sierra will be posting connection info for the conference call on her site on Saturday morning!"
LLY has $5.4B in cash, but also $5.3B in debt according to Yahoo. They certainly could afford to pay $25 per share ($1B) for CYTR but my guess is that CYTR will sign a partnership with them or someone else instead....JMO. Why would management give up a potential $50-$100 per share when Aldo gets FDA approval to get $25 per share now? They can have their cake and eat it too....they can get to $20 per share on a partnership news and keep the drug for most indications and keep their other 3 drugs in clinicals and still get $50 or more per share when the FDA approval comes....JMO.